Navigation Links
Fish extinctions alter critical nutrients in water, study shows

ber of species were lost.

Studies of complex ecosystems, especially those involving large, highly mobile fish, are almost impossible to carry out in the wild, but new methods are helping researchers better understand these systems.

"Computer simulations provide a means to assess patterns of species loss in a system in which we just cannot do complex experiments," said co-author Alex Flecker, Cornell associate professor of ecology and evolutionary biology, who served as McIntyre's adviser. "But we have to be aware that there is a whole set of assumptions that goes into simulating species loss."

For example, it is unknown whether surviving species can truly compensate for extinctions. In a study of two species of fish in the Venezuelan river that eat mud from the river bottom, Flecker found that the rarer of the two species was unable to make up for the loss of the more common one. Thus, it appears that human overfishing of the common species, coporo (Prochilodus mariae), may have large effects on the ecosystem, in part because of its large contribution to nitrogen recycling.

The current study also revealed that species that heavily recycle nitrogen are not always the same ones that recycle the most phosphorus. These differences would make it difficult for conservationists to prioritize species to protect.
'"/>

Source:Cornell University News Service


Page: 1 2

Related biology news :

1. Super predators and mass extinctions
2. New study pinpoints epicenters of Earths imminent extinctions
3. Climate change drives widespread amphibian extinctions
4. Man may have caused pre-historic extinctions
5. Birth rate, competition are major players in hominid extinctions
6. Improved predictions of warming-induced extinctions sought
7. Products containing specific probes for detecting alternative splice forms protected
8. Compounds in plastic packaging act as environmental estrogens altering breast genes
9. Plant pathologists evaluate eco-friendly alternatives to methyl bromide
10. New technique could alter field of mouse genetics
11. Genetic variation alters response to common anti-clotting drug
Post Your Comments:
(Date:12/11/2009)... Motulsky, the senior editor of the 4th edition of ... Genetics, was recently given the Victor A. McKusick Leadership ... to the field of human genetics, was presented to ... Society of Human Genetics on 24 October 2009 in ... and Genome Sciences at the University of Washington in ...
(Date:12/11/2009)... German . , Halle/Saale. With increasing ... extinctions, plant communities of many European regions are ... more frequently, whereas rare species are becoming extinct. ... are becoming increasingly similar, but also the phylogenetic ... a loss of uniqueness among European floras, scientists ...
(Date:12/10/2009)... -- Kornberg Associates | Architects ( www.kornberg.com ) ... Hall), including a previously unused covered open area, ... the University of California, Riverside. Ken Kornberg, ... ,, "A key project element was to ensure ... campus security system, access control is independent from ...
Breaking Biology News(10 mins):Europe's flora is becoming impoverished 2Europe's flora is becoming impoverished 3Kornberg Associates | Architects Completes UC Riverside Stem Cell Core Facility Project 2AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 1AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 2Frost 26 Sullivan 3A Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation 48159 1Frost 26 Sullivan 3A Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation 48159 2Frost 26 Sullivan 3A Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation 48159 3Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 1Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 2Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 3
... inflammation triggers bone marrow-derived blood cells to travel to ... neuron up to 100 times more frequently than previously ... University School of Medicine. , After the fusion, the ... The surprise finding in mice suggests that the creation ...
... simulation has revealed a self-healing behavior in a ... radiation-resistant materials for nuclear power plants and waste ... Energy,s Pacific Northwest National Laboratory found that the ... in the engineered ceramic yttria-stabilized zirconia. , ...
... German . , Researchers at the ... new strategy for the formation of hybrid materials from ... to fuse the specific biological functions of proteins with ... hybrid materials may be of use in the manufacture ...
Other Biology News:Inflammation triggers cell fusions that could protect neurons, Stanford research shows 2Inflammation triggers cell fusions that could protect neurons, Stanford research shows 3Inflammation triggers cell fusions that could protect neurons, Stanford research shows 4Ceramic, heal thyself 2Green gel 2
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... Dec. 11 Ambit Biosciences Corporation announced today ... M. D. Anderson Cancer Center of the first patient ... E fficacy) Phase 2 pivotal trial ... (AML). AC220 is a novel, orally available, potent ... as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ...
(Date:12/11/2009)... Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, ... announced the appointment of Dr. Alan Warrander to ... and Business Development. ,, "Dr. Warrander will be ... strategy for REOLYSIN(R)," said Dr. Brad Thompson, President ... on the design of a Phase 3 trial ...
(Date:12/10/2009)... Endologix, Inc. (Nasdaq: ELGX ), developer of ... that Dan Lemaitre, former President and CEO of ... effective December 11, 2009. Endologix now has ... Franklin D. Brown, Chairman of the Board, said, ... the Endologix Board of Directors. He has ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2
... NLTX ), today announced preliminary data from its recently completed multi-center, open-label, ... in patients with heart failure. Results of this study showed: , ... CD-NP was well tolerated at doses of ... pressure effects were dose dependent and well characterized , ...
... Systems, Inc. (Nasdaq: DCTH ) today announced the appointment ... Dr. Stoll is Executive Chairman of Cortex Pharmaceuticals, Inc. (Amex: ... central nervous system disorders. , , ... , Prior to joining Cortex, Dr. Stoll worked ...
... International Corporation,(Nasdaq: PRXL ), a leading ... established an alliance with Safe Implementation,of Treatments in ... sites with specialized capabilities in the area of ... access to more than 800,investigator sites located in ...
Other Biology Technology:Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure 2Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure 3Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure 4Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure 5Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors 2Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors 3PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 2PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 3PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 4